FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068506581> ?p ?o ?g. }

• W2068506581 endingPage "1614" @default.
• W2068506581 startingPage "1607" @default.
• W2068506581 abstract "The cause and pathogenesis of chronic urticaria are still poorly understood. IgE-independent reactions, are common in adult patients with chronic urticaria, who have daily spontaneous occurrence of weals. H(1)-receptor antagonists (antihistamines) are the major class of therapeutic agents used in the management of urticaria and angioedema. Nevertheless, chronic urticaria is often difficult to treat and may not be controlled by antihistamines alone. It has been postulated that mediators other than histamine, such as kinins, prostaglandin and leukotrienes, may be responsible for some of the symptoms in urticaria which are not controlled by antihistamines. In this study, which was randomized double-blind, placebo-controlled, we compare the clinical efficacy and safety of montelukast (MT) 10 mg given once a day and cetirizine (CET) 10 mg given once a day with placebo (PLA), in the treatment of patients with chronic urticaria who have positive challenge to acetylsalicylic acid (ASA) and/or food additives.A group of 51 patients, ranging in age from 15 to 71 years, with chronic urticaria and positive challenge to food additives and/or ASA, participated in this study for a period of 4 weeks, starting from a 3-day run-in. The assessment of the efficacy was based on scores of daily urticaria symptoms.MT significantly increased the percentage of symptom-free days for hive and itch. Analysis of frequency distribution of urticaria scores for each symptom gave similar results (MT vs. CET and MT vs. PLA, P < 0.001). The interference with sleep due to their skin condition was also lower in the group treated with MT (P < 0.001). In addition, the median number of days without the rescue medication was significantly higher in the MT group (24 days) than both the CET and the PLA groups (18 days, P < 0.001, and 20 days, P < 0.001, respectively). Finally, a low incidence of adverse events was observed in this study.The results of this comparative study demonstrate that montelukast orally administered once a day is very effective for the treatment of cutaneous symptoms in patients with chronic urticaria due to food additives and/or ASA." @default.
• W2068506581 created "2016-06-24" @default.
• W2068506581 creator A5065645344 @default.
• W2068506581 creator A5067811540 @default.
• W2068506581 creator A5074863074 @default.
• W2068506581 date "2001-10-01" @default.
• W2068506581 modified "2023-10-18" @default.
• W2068506581 title "Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid" @default.
• W2068506581 cites W190003161 @default.
• W2068506581 cites W1972848214 @default.
• W2068506581 cites W1980657378 @default.
• W2068506581 cites W1980709890 @default.
• W2068506581 cites W1980832959 @default.
• W2068506581 cites W1983770190 @default.
• W2068506581 cites W1985943314 @default.
• W2068506581 cites W1988931744 @default.
• W2068506581 cites W2002008041 @default.
• W2068506581 cites W2005873197 @default.
• W2068506581 cites W2011076028 @default.
• W2068506581 cites W2013764600 @default.
• W2068506581 cites W2023435913 @default.
• W2068506581 cites W2027113367 @default.
• W2068506581 cites W2027813069 @default.
• W2068506581 cites W2030027930 @default.
• W2068506581 cites W2032142894 @default.
• W2068506581 cites W2039350065 @default.
• W2068506581 cites W2043603230 @default.
• W2068506581 cites W2043867178 @default.
• W2068506581 cites W2055599580 @default.
• W2068506581 cites W2058038307 @default.
• W2068506581 cites W2058639150 @default.
• W2068506581 cites W2069312752 @default.
• W2068506581 cites W2074667964 @default.
• W2068506581 cites W2074818871 @default.
• W2068506581 cites W2075931251 @default.
• W2068506581 cites W2085868451 @default.
• W2068506581 cites W2087019177 @default.
• W2068506581 cites W2090429941 @default.
• W2068506581 cites W2113410918 @default.
• W2068506581 cites W2325612100 @default.
• W2068506581 cites W2397068357 @default.
• W2068506581 cites W4245107297 @default.
• W2068506581 doi "https://doi.org/10.1046/j.1365-2222.2001.01189.x" @default.
• W2068506581 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11678862" @default.
• W2068506581 hasPublicationYear "2001" @default.
• W2068506581 type Work @default.
• W2068506581 sameAs 2068506581 @default.
• W2068506581 citedByCount "146" @default.
• W2068506581 countsByYear W20685065812012 @default.
• W2068506581 countsByYear W20685065812013 @default.
• W2068506581 countsByYear W20685065812014 @default.
• W2068506581 countsByYear W20685065812015 @default.
• W2068506581 countsByYear W20685065812016 @default.
• W2068506581 countsByYear W20685065812017 @default.
• W2068506581 countsByYear W20685065812018 @default.
• W2068506581 countsByYear W20685065812019 @default.
• W2068506581 countsByYear W20685065812020 @default.
• W2068506581 countsByYear W20685065812021 @default.
• W2068506581 countsByYear W20685065812022 @default.
• W2068506581 crossrefType "journal-article" @default.
• W2068506581 hasAuthorship W2068506581A5065645344 @default.
• W2068506581 hasAuthorship W2068506581A5067811540 @default.
• W2068506581 hasAuthorship W2068506581A5074863074 @default.
• W2068506581 hasConcept C10335311 @default.
• W2068506581 hasConcept C1122143 @default.
• W2068506581 hasConcept C126322002 @default.
• W2068506581 hasConcept C142724271 @default.
• W2068506581 hasConcept C170493617 @default.
• W2068506581 hasConcept C203014093 @default.
• W2068506581 hasConcept C204787440 @default.
• W2068506581 hasConcept C27081682 @default.
• W2068506581 hasConcept C2776042228 @default.
• W2068506581 hasConcept C2776322731 @default.
• W2068506581 hasConcept C2776885963 @default.
• W2068506581 hasConcept C2777995640 @default.
• W2068506581 hasConcept C2779463773 @default.
• W2068506581 hasConcept C2780212800 @default.
• W2068506581 hasConcept C3017745231 @default.
• W2068506581 hasConcept C71924100 @default.
• W2068506581 hasConcept C90924648 @default.
• W2068506581 hasConceptScore W2068506581C10335311 @default.
• W2068506581 hasConceptScore W2068506581C1122143 @default.
• W2068506581 hasConceptScore W2068506581C126322002 @default.
• W2068506581 hasConceptScore W2068506581C142724271 @default.
• W2068506581 hasConceptScore W2068506581C170493617 @default.
• W2068506581 hasConceptScore W2068506581C203014093 @default.
• W2068506581 hasConceptScore W2068506581C204787440 @default.
• W2068506581 hasConceptScore W2068506581C27081682 @default.
• W2068506581 hasConceptScore W2068506581C2776042228 @default.
• W2068506581 hasConceptScore W2068506581C2776322731 @default.
• W2068506581 hasConceptScore W2068506581C2776885963 @default.
• W2068506581 hasConceptScore W2068506581C2777995640 @default.
• W2068506581 hasConceptScore W2068506581C2779463773 @default.
• W2068506581 hasConceptScore W2068506581C2780212800 @default.
• W2068506581 hasConceptScore W2068506581C3017745231 @default.
• W2068506581 hasConceptScore W2068506581C71924100 @default.
• W2068506581 hasConceptScore W2068506581C90924648 @default.
• W2068506581 hasIssue "10" @default.

• next